JYOTHYLAB / Q2-FY26 / risks

Keep the risk register visible.

Jyothy Labs · Material risks, their source context, and severity in the latest available quarter.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

WatchQ2-FY26 · source date pendingBack to quarter ↗

Risk intelligence

Material risks this quarter

HI segment loss-making and extended turnaround timeline

Household insecticides has been unprofitable for over 3 years. Despite new product launches (maxi aerosols, anti-mosquito rackets), management indicates a 4-6 quarter timeline for profitability, representing continued drag on overall earnings.

medium

Personal care margin recovery uncertainty

Analyst questioned whether personal care margins at -4% can recover to double-digit levels in Q3. Management attributed margin compression to one-time Margo brand investments, prior price increases impacting volumes, and 14-15% input cost inflation. Recovery timeline of 'a couple of quarters' leaves uncertainty.

medium

GST disruption quantification challenge

Management repeatedly deflected questions asking to quantify the GST disruption impact, stating it was 'difficult to put a number'. This lack of specificity makes it challenging to assess underlying demand trends and normalize Q3 expectations appropriately.

medium

Channel mix shift increasing working capital

Working capital days increased from 19 to 22 days due to growing share from modern trade/e-commerce/quick commerce (now ~1/3rd of business from ~1/3rd previously) which have longer credit cycles. This structural shift may continue to pressure cash conversion.

low